10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $264,296 | +1.7% | 4,733 | +1.6% | 0.00% | – |
| Q1 2023 | $259,975 | -66.9% | 4,660 | -78.4% | 0.00% | -100.0% |
| Q4 2022 | $784,492 | +57.2% | 21,528 | +22.8% | 0.00% | 0.0% |
| Q3 2022 | $499,000 | -51.7% | 17,532 | -23.3% | 0.00% | -50.0% |
| Q2 2022 | $1,034,000 | -38.3% | 22,861 | +3.7% | 0.00% | 0.0% |
| Q1 2022 | $1,677,000 | -37.8% | 22,040 | +21.7% | 0.00% | -50.0% |
| Q4 2021 | $2,698,000 | +293.9% | 18,113 | +285.1% | 0.00% | +300.0% |
| Q3 2021 | $685,000 | -30.0% | 4,704 | -5.8% | 0.00% | 0.0% |
| Q2 2021 | $978,000 | -57.4% | 4,991 | -60.6% | 0.00% | -75.0% |
| Q1 2021 | $2,296,000 | +134.0% | 12,682 | +83.1% | 0.00% | +100.0% |
| Q4 2020 | $981,000 | +373.9% | 6,927 | +155.7% | 0.00% | – |
| Q4 2019 | $207,000 | – | 2,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |